Senior insider sale
Chief Financial Officer at BICARA THERAPEUTICS INC. — senior position signals high conviction
$718.7K
36.80K shares
What this filing means
HYEP IVAN plans to sell 36.80K shares of BICARA THERAPEUTICS INC. valued at approximately $718.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/21/2026ACC: 0001969223-26-000461
Officer· Chief Financial Officer
Since Mar 2026
36.80K
Shares to sell
$718.7K
Approx. market value
9.20K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of stock options
Cash
4/21/2026
9.20KTotal acquired9.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/21/2026 | Exercise of stock options Cash | 9.20K | — |
| Total | 9.20K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
9.20K
Market value
$170.3K
3/23/2026
—Completed
Units to sell
2.96K
Market value
$54.1K
3/4/2026
—Completed
Units to sell
13.55K
Market value
$246.9K
3/3/2026
—Completed
Units to sell
1.88K
Market value
$34.2K
1/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.20K
Market value
$213.2K
4/21/2026
Total
Units
36.80K
Value
$718.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/23/2026 | 9.20K | $170.3K | — | Completed |
3/4/2026 | 2.96K | $54.1K | — | Completed |
3/3/2026 | 13.55K | $246.9K | — | Completed |
1/22/2026 | 1.88K | $34.2K | — | Completed |
| Planned — Approximate Date | ||||
4/21/2026 | 9.20K | $213.2K | NASDAQ | Planned |
| Total | 36.80K | $718.7K | ||